col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


38 Ergebisse       Seite 1

 [1] 
Springer (Biomed Central Ltd.): Journal of Hematology & Oncology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Mrz―27 Identification of SARS-CoV-2-specific T cell and its receptor Qian Zhang, Qing Liang, Rui Zhang, Nan Wang, Xu Xiao, Jiahao Shao, Kejia Wang
2 [GO] 2023―Mai―03 Antibody response to SARS-CoV-2 WT and Omicron BA.4/5 of inactivated COVID-19 vaccine in patients with lung cancer after second and booster immunization Chen Chen, Liyuan Dai, Cuiling Zheng, Haolong Li, Xiaomeng Li, Mengwei Yang, et al. (+5)
3 [GO] 2023―Apr―13 Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients Yan Leyfman, Nancy Emmanuel, Gayathri P. Menon, Muskan Joshi, William B. Wilkerson, Jared Cappelli, et al. (+3)
4 [GO] 2023―Apr―03 Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio, Federico Itri, Caroline Besson, Julio Dávila-Valls, et al. (+35)
5 [GO] 2023―Feb―21 Correction: SELP Asp603Asn and severe thrombosis in COVID-19 males Chiara Fallerini, Sergio Daga, Elisa Benetti, Nicola Picchiotti, Kristina Zguro, Francesca Catapano, et al. (+17)
6 [GO] 2022―Nov―28 Pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) prevents severe SARS-CoV-2 infection in recipients of allogeneic hematopoietic stem cell transplantation during the Omicron wave: a multicentric retrospective study of SFGM-TC Ludovic Jondreville, Maud D’Aveni, Hélène Labussière-Wallet, Amandine Le Bourgeois, Alban Villate, Ana Berceanu, et al. (+8)
7 [GO] 2022―Aug―26 Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL Darko Antic, Natasa Milic, Thomas Chatzikonstantinou, Lydia Scarfò, Vladimir Otasevic, Nina Rajovic, et al. (+95)
8 [GO] 2022―Aug―16 Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients Manuela De Michele, Giulia d’Amati, Martina Leopizzi, Marta Iacobucci, Irene Berto, Svetlana Lorenzano, et al. (+4)
9 [GO] 2022―Jun―16 Immune response to vaccination against SARS-CoV-2 in hematopoietic stem cell transplantation and CAR T-cell therapy recipients Xi Wu, Lu Wang, Lu Shen, Lin He, Kefu Tang
10 [GO] 2022―Mai―31 Correction to: COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study Jadwiga Węcławek-Tompol, Zuzanna Zakrzewska, Olga Gryniewicz-Kwiatkowska, Filip Pierlejewski, Ewa Bień, Agnieszka Zaucha-Prażmo, et al. (+23)
11 [GO] 2022―Mai―21 Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study Anthony Rooney, Cory Bivona, Ben Liu, David Streeter, Han Gong, Qamar Khan
12 [GO] 2022―Mai―19 Safety of two-dose COVID-19 vaccination (BNT162b2 and CoronaVac) in adults with cancer: a territory-wide cohort study Wei Kang, Jessica J. P. Shami, Vincent K. C. Yan, Xuxiao Ye, Joseph E. Blais, Xue Li, et al. (+7)
13 [GO] 2022―Mai―07 SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders José Luis Piñana, Lucia López-Corral, Rodrigo Martino, Lourdes Vazquez, Ariadna Pérez, Gabriel Martin-Martin, et al. (+22)
14 [GO] 2022―Mrz―18 Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, Florence Beckerich, Christine Robin, Vincent Parinet, et al. (+8)
15 [GO] 2022―Feb―05 Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis Atsushi Sakuraba, Alexander Luna, Dejan Micic
16 [GO] 2022―Jan―10 Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology No-Joon Song, Carter Allen, Anna E. Vilgelm, Brian P. Riesenberg, Kevin P. Weller, Kelsi Reynolds, et al. (+24)
17 [GO] 2022―Jan―10 Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia P. Guisado-Vasco, M. M. Carralón-González, J. Aguareles-Gorines, E. M. Martí-Ballesteros, M. D. Sánchez-Manzano, D. Carnevali-Ruiz, et al. (+9)
18 [GO] 2022―Jan―09 Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia Helen Parry, Graham McIlroy, Rachel Bruton, Sarah Damery, Grace Tyson, Nicola Logan, et al. (+18)
19 [GO] 2021―Nov―13 Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies Ilya Tsimafeyeu, Maria Volkova, Galina Alekseeva, Maria Berkut, Alexander Nosov, Igor Myslevtsev, et al. (+8)
20 [GO] 2021―Okt―19 Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study Angel Y. S. Wong, Laurie A. Tomlinson, Jeremy P. Brown, William Elson, Alex J. Walker, Anna Schultze, et al. (+24)
21 [GO] 2021―Okt―14 COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alessandro Busca, Paolo Corradini, Martin Hoenigl, et al. (+189)
22 [GO] 2021―Okt―13 Response to COVID-19 mRNA vaccination in multiple myeloma is conserved but impaired compared to controls Samuel Bitoun, Julien Henry, Christelle Vauloup-Fellous, Nicolas Dib, Rakiba Belkhir, Lina Mouna, et al. (+7)
23 [GO] 2021―Okt―11 COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study Jadwiga Węcławek-Tompol, Zuzanna Zakrzewska, Olga Gryniewicz-Kwiatkowska, Filip Pierlejewski, Ewa Bień, Agnieszka Zaucha-Prażmo, et al. (+21)
24 [GO] 2021―Aug―16 SELP Asp603Asn and severe thrombosis in COVID-19 males Chiara Fallerini, Sergio Daga, Elisa Benetti, Nicola Picchiotti, Kristina Zguro, Francesca Catapano, et al. (+17)
25 [GO] 2021―Jun―04 Hemophagocytic lymphohistiocytosis after COVID-19 vaccination Liang V. Tang, Yu Hu
26 [GO] 2021―Jun―04 Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors Evangelos Terpos, Flora Zagouri, Michalis Liontos, Aimilia D. Sklirou, Konstantinos Koutsoukos, Christos Markellos, et al. (+4)
27 [GO] 2021―Apr―29 SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism Shu Shen, Jingyuan Zhang, Yaohui Fang, Sihong Lu, Jun Wu, Xin Zheng, Fei Deng
28 [GO] 2021―Apr―17 Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study Anouk H. Eijkelboom, Linda de Munck, Marie-Jeanne T. F. D. Vrancken Peeters, Mireille J. M. Broeders, Luc J. A. Strobbe, Monique E. M. M. Bos, et al. (+14)
29 [GO] 2021―Feb―27 COVID-19 vaccines for patients with cancer: benefits likely outweigh risks Joyce K. Hwang, Tian Zhang, Andrew Z. Wang, Zihai Li
30 [GO] 2020―Dez―11 Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients Gaili Chen, Qiuji Wu, Huangang Jiang, Zheng Li, Xinying Hua, Xiaoyan Hu, et al. (+3)
31 [GO] 2020―Dez―01 Thrombocytopenia and thrombosis in hospitalized patients with COVID-19 Heng Mei, Lili Luo, Yu Hu
32 [GO] 2020―Nov―04 The impact of the temporary suspension of national cancer screening programmes due to the COVID-19 epidemic on the diagnosis of breast and colorectal cancer in the Netherlands Avinash G. Dinmohamed, Matteo Cellamare, Otto Visser, Linda de Munck, Marloes A. G. Elferink, Pieter J. Westenend, et al. (+6)
33 [GO] 2020―Okt―08 Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study Julio García-Suárez, Javier de la Cruz, Ángel Cedillo, Pilar Llamas, Rafael Duarte, Víctor Jiménez-Yuste, et al. (+36)
34 [GO] 2020―Okt―02 Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia Guido Lancman, John Mascarenhas, Michal Bar-Natan
35 [GO] 2020―Sep―04 SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19 Si Zhang, Yangyang Liu, Xiaofang Wang, Li Yang, Haishan Li, Yuyan Wang, et al. (+11)
36 [GO] 2020―Jul―14 A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward Bo Wang, Oliver Van Oekelen, Tarek H. Mouhieddine, Diane Marie Del Valle, Joshua Richter, Hearn Jay Cho, et al. (+7)
37 [GO] 2020―Jun―15 Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis Yifan Meng, Wanrong Lu, Ensong Guo, Jia Liu, Bin Yang, Ping Wu, et al. (+16)
38 [GO] 2020―Mai―04 Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis Peiwei Chai, Jie Yu, Shengfang Ge, Renbing Jia, Xianqun Fan
 [1] 

38 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.007 sec